Contrast-enhanced Ultrasound in Follow-up After Endovascular Aneurysm Repair

Access Programs

Disease Information

Descriptive Information
Brief Title † Contrast-enhanced Ultrasound in Follow-up After Endovascular Aneurysm Repair
Official Title † Contrast-enhanced Ultrasound in Follow-up After Endovascular Aneurysm Repair
Brief Summary X-ray computed tomography imaging (CT) is routinely used in follow-up after endovascular aneurysm repair (EVAR). Contrast-enhanced ultrasound (CEUS) has been shown to give accurate information about endoleak after EVAR. Benefits of CEUS over CT include less radiation exposure, avoidance of renal function deterioration due to repeated X-ray contrast agent application and decrease in the cost of EVAR follow-up. This study is designed to investigate if results from literature are reproducible in St Olavs Hospital in Trondheim (Norway), to gain experience with the technique and to introduce CEUS as an alternative for detection of endoleak in this hospital.
Detailed Description
Study Phase N/A
Study Type † Observational
Study Design †
Primary Outcome Measure † Detection of endoleak with CEUS
Secondary Outcome Measure †
Condition † Abdominal Aortic Aneurysm Endoleak
Intervention †
Study Arms / Comparison Groups
Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information
Recruitment Status †
Estimated Enrollment † 60
Start Date † September 2014
Completion Date June 2017
Primary Completion Date June 2017
Eligibility Criteria † Inclusion Criteria: - in follow-up after endovascular implantation of abdominal aortic prothesis Exclusion Criteria:
Gender All
Ages N/A - N/A
Accepts Healthy Volunteers No
Contacts ††
Location Countries † Norway
Administrative Information
NCT ID † NCT01843335
Organization ID 2013/359/REKnord
Secondary IDs ††
Responsible Party Sponsor
Study Sponsor † Norwegian University of Science and Technology
Collaborators †† St. Olavs Hospital
Investigators † Study Director: Reidar Brekken, PhD, NTNU
Information Provided By
Verification Date February 2017
First Received Date † April 26, 2013
Last Updated Date February 2, 2017
† Required WHO trial registration data element.
†† WHO trial registration data element that is required only if it exists.
Find a Clinical Trial
Trending videos
by Abidemi Uruejoma
by Christine DuBois
by Abidemi Uruejoma
Free Newsletter